✦ LIBER ✦

Percutaneous Interventional Therapies for the Treatment of Patients With Severe Pulmonary Hypertension

✍ Scribed by Bhamra-Ariza, Paul; Keogh, Anne M.; Muller, David W.M.

Book ID: 121512698
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 763 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.11.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antioxidants for the Treatment of Patien

Antioxidants for the Treatment of Patients with Severe Angioproliferative Pulmonary Hypertension?

✍ Voelkel, Norbert F.; Bogaard, Harm J.; Husseini, Aysar Al; Farkas, Laszlo; Gomez 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 556 KB

Acute coronary syndrome due to extrinsic

Acute coronary syndrome due to extrinsic compression of the left main coronary artery in a patient with severe pulmonary hypertension: successful treatment with percutaneous coronary intervention

✍ Jason B. Lindsey; Emmanouil S. Brilakis; Subhash Banerjee 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Advances in the Management of Pulmonary

Advances in the Management of Pulmonary Arterial Hypertension || Current therapies for the treatment of pulmonary arterial hypertension

✍ Smith, Kimberly A; Fraidenburg, Dustin R; Yuan, Jason X-J 📂 Article 📅 2013 🏛 Future Medicine Ltd ⚖ 922 KB

Transcatheter intervention following amb

Transcatheter intervention following ambrisentan treatment in an adult patient with patent ductus arteriosus and severe pulmonary hypertension

✍ Yunfei, Ling; Ke, Lin; Qi, An; Yuan, Feng 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Oral nifedipine for the treatment of pat

Oral nifedipine for the treatment of patients with severe hypertension

✍ Robert C. Davidson; Stuart L. Bursten; Pamela A. Keeley; Margaret A. Kenny; Doug 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 524 KB

Long-term iloprost infusion therapy for

Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases

✍ Jose De La Mata; Miguel A. Gomez-Sanchez; Mercedes Aranzana; Juan J. Gomez-Reino 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had